Bruno Castro

@brunommcastro.bsky.social

Senior Editor @NatureMaterials. Views are my own.

Our last issue of 2025 issue is online! Featuring a Focus on scalable quantum photonics and articles on qubit quantum sensors, 2D polyamide for anode-free batteries, plasmonic printing of metal electronics, hermetic stretchable seals and more. See it below!👇 go.nature.com/48mFlP0

Nature Materials - Quantum photonics on a chip

Photonic technologies enable on-chip, scalable solutions for applications in quantum communications, quantum sensing and quantum computing.See Wang et al.

go.nature.com

We have observed a beautifully strange phenomenon of phase separation by human monocytes placed on soft matrix, which do it for survival. We model it by incorporating the Cahn–Hilliard equation with a Turing mechanism of local activation/global inhibition More here: www.nature.com/articles/s41...

Mechano-induced patterned domain formation by monocytes - Nature Materials

Human primary monocytes reversibly phase separate into regular, multicellular, multilayered domains on soft matrices with physiological stiffness due to local activation and global inhibition processe...

nature.com

Join us for the first @embo.org meeting on Intracellular mechanics and organelle mechanobiology! Registrations are open, submit your abstract by November 14: we have plenty of slots for short talks! #EMBOMechanobio

Felix Campelo@felixmendu.bsky.social · last yr.

Announcing a new @embo.org Workshop on "Intracellular mechanics and organelle mechanobiology" that we are organizing with Michael Krieg and Verena Ruprecht at @icfo.eu (Barcelona) on 16-20 February, 2026. Please, repost and spread the word! 🙏 #EMBOmechanobio meetings.embo.org/event/26-org...

🚨Join us! We're soon opening 3 postdoctoral positions in #AIDrivenBiology. Seeking biologists (especially microbiology and infection biology), computer scientists, and microscopy developers. Ideal candidates are those eager to use or develop next-gen tech for cell biology. Get in touch (DM/email)

BildBild

A single dose of commercial CAR-T therapy costs around $500,000. So a great deal of work is going into in vivo treatments - engineering T cells inside the body- that might cost an order of magnitude less. Fascinating! 🧪 @nature.com www.nature.com/articles/d41...

Cancer-fighting immune cells could soon be engineered inside our bodies

Manufacturing CAR T cells in the laboratory is expensive and time-consuming. An in vivo approach could get the powerful therapy to more people.

nature.com